 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval! m# ]$ G+ I9 _* q
7 f* U! P, t. B- ^8 Z& t
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.) w* | a8 B1 x/ l9 A+ h
& |- Y5 c% @; b: b, X' {/ `. ABY THE EDMONTON JOURNAL FEBRUARY 16, 2007
/ O/ u Z; V$ H- q) I7 D
9 X9 C4 f/ o, b2 x2 [/ t 3 | V" L0 j( h" s; a# ~9 Y
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.7 L7 U' i4 B$ e& n6 y) u
( m& M- Y( C1 x; w" J5 MThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM." g4 Z2 X8 T( ]
2 E9 m" {) D1 c1 n2 f c" W
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.2 c# k% T1 {9 ], `5 h! Z
' S6 G/ s# A" g# I0 G% fIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
- `3 N5 |3 X! `+ m4 [+ X' S; r5 [( o
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
. s0 h! u9 Z0 T! c4 b1 r
' g7 E( e& A4 ?' l6 x/ f"As a scientist, it's one of the highlights of my CAREER," Shan said.
8 s5 E1 A# \% l1 E, K
1 T4 Y1 Y, G5 S5 d4 j4 F& p& c9 l& X"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."; @* g+ p" I9 Y; i$ n) I) t
3 U, V4 D9 X1 r& iIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
& c5 p* j4 z7 t9 r, K+ V: [8 l7 x/ V
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.- ~$ \ u# C8 h3 T% ^, Y( k
6 m/ z4 O% J. f+ f
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.1 s# |) A1 O& `: n
2 c# O/ j! y$ c& {: r9 }* B
7 P1 g2 @! Q+ u: \6 ^7 [http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
r) q+ e- G9 n k! {
发表于 2015-2-28 19:45
